Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	NOD-like receptor signaling pathway	6/181	2.2716519598648245e-08	1.113109460333764e-06	67.65428571428572	-217.27332348682836	CASP1;GSDMD;IL1B;NEK7;NLRC4;PYCARD
KEGG_2021_Human	Legionellosis	4/57	4.533460591014752e-07	1.1106978447986143e-05	100.81761006289308	-216.95395722754864	CASP1;IL1B;NLRC4;PYCARD
KEGG_2021_Human	Pertussis	4/76	1.4558243895816926e-06	2.3778465029834313e-05	74.03703703703704	-172.05130589538587	CASP1;IL1A;IL1B;PYCARD
KEGG_2021_Human	Salmonella infection	5/249	5.936720067831368e-06	7.272482083093427e-05	32.0655737704918	-103.35956009638306	CASP1;GSDMD;IL1B;NLRC4;PYCARD
KEGG_2021_Human	Yersinia infection	4/137	1.5363738345825308e-05	0.00015056463578908802	39.774436090225564	-104.03256013781805	CASP1;IL1B;NLRC4;PYCARD
KEGG_2021_Human	Necroptosis	4/159	2.7677777198301538e-05	0.0002260351804527959	34.034408602150535	-90.91492941118791	CASP1;IL1A;IL1B;PYCARD
KEGG_2021_Human	Influenza A	4/172	3.7714889820243616e-05	0.00026400422874170535	31.349206349206348	-84.54495262531024	CASP1;IL1A;IL1B;PYCARD
KEGG_2021_Human	Cytosolic DNA-sensing pathway	3/63	5.21817057256637e-05	0.0003196129475696902	57.2	-103.63746645388204	CASP1;IL1B;PYCARD
KEGG_2021_Human	Lipid and atherosclerosis	4/215	9.035438443106581e-05	0.0004919294263469138	24.824644549763033	-68.34725873383007	CASP1;IL1B;NFE2L2;PYCARD
KEGG_2021_Human	Shigellosis	4/246	0.00015252097444894315	0.0007473527747998214	21.55922865013774	-59.801482853342776	CASP1;IL1B;NLRC4;PYCARD
KEGG_2021_Human	C-type lectin receptor signaling pathway	3/104	0.0002329673917108638	0.0010377638358029387	33.806223479490804	-67.40758155759835	CASP1;IL1B;PYCARD
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.0022361630548177773	24.99579831932773	-51.672386684351224	IL1A;IL1B;NFE2L2
KEGG_2021_Human	Type I diabetes mellitus	2/43	0.0012123028259538784	0.004243059890838574	48.94512195121951	-56.84526782917664	IL1A;IL1B
KEGG_2021_Human	Graft-versus-host disease	2/42	0.0011566808072543669	0.004243059890838574	50.175	-57.95352918467438	IL1A;IL1B
KEGG_2021_Human	Pathogenic Escherichia coli infection	3/197	0.0015104299457678824	0.004934071156175082	17.394698085419734	-36.72187076283526	CASP1;IL1B;PYCARD
KEGG_2021_Human	Inflammatory bowel disease	2/65	0.002752148243719554	0.008428453996391135	31.765873015873016	-40.07734547796954	IL1A;IL1B
KEGG_2021_Human	Leishmaniasis	2/77	0.0038409427449733026	0.011070952617864225	26.643333333333334	-34.49723066158141	IL1A;IL1B
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.015126346716243083	21.914835164835164	-29.03004575134454	IL1A;IL1B
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.01567945662726076	20.331632653061224	-27.120602948412195	IL1A;IL1B
KEGG_2021_Human	Hematopoietic cell lineage	2/99	0.006275930773922806	0.01567945662726076	20.54381443298969	-27.37901341152302	IL1A;IL1B
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.02370975674207599	15.886	-21.510038502238015	IL1A;IL1B
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.026915150072270102	14.472627737226277	-19.639406588988233	IL1A;IL1B
KEGG_2021_Human	Non-alcoholic fatty liver disease	2/155	0.014879426053803059	0.03169964681027608	12.933006535947712	-17.54750234216727	IL1A;IL1B
KEGG_2021_Human	Tuberculosis	2/180	0.019755026308062106	0.040333178712293465	11.081460674157304	-14.950240051620256	IL1A;IL1B
KEGG_2021_Human	Neutrophil extracellular trap formation	2/189	0.02165639204960556	0.042446528417226896	10.536096256684491	-14.167050995225416	CASP1;GSDMD
KEGG_2021_Human	Coronavirus disease	2/232	0.03174764714886429	0.05983210424209039	8.519565217391305	-11.194266119915625	CASP1;IL1B
KEGG_2021_Human	Prion disease	2/273	0.04281158988095726	0.07769510756173727	7.192804428044281	-9.169844698845731	IL1A;IL1B
KEGG_2021_Human	African trypanosomiasis	1/37	0.04489527895199197	0.07856673816598594	24.790123456790123	-13.876145105511855	IL1B
KEGG_2021_Human	MAPK signaling pathway	2/294	0.04897898942595734	0.0804918036659451	6.657534246575342	-8.337786615237395	IL1A;IL1B
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.0804918036659451	6.6339590443686	-8.300944532041967	IL1A;IL1B
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.09520741287851557	18.183673469387756	-10.63265628196324	IL1B
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.11250229327422226	5.2459128065395095	-6.1057863985118	IL1A;IL1B
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.15277969248087778	8.592233009708737	-5.152341092635986	IL1B
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.15277969248087778	8.764576457645765	-5.262086311101535	IL1B
KEGG_2021_Human	Inflammatory mediator regulation of TRP channels	1/98	0.11496450084552494	0.15277969248087778	9.130584192439862	-5.49346810373269	IL1B
KEGG_2021_Human	IL-17 signaling pathway	1/94	0.11051569770952978	0.15277969248087778	9.528076463560334	-5.7422174156532195	IL1B
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.15277969248087778	8.764576457645765	-5.262086311101535	IL1B
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.15277969248087778	8.592233009708737	-5.152341092635986	IL1B
KEGG_2021_Human	Pathways of neurodegeneration	2/475	0.11356791602477233	0.15277969248087778	4.014270613107822	-4.131104230952899	IL1A;IL1B
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.15300393817463315	8.345911949685535	-4.994589105830365	IL1B
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.1558176759343722	7.964964964964965	-4.748494648054986	IL1B
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.20680421514004402	5.672401433691756	-3.209640069203435	IL1A
KEGG_2021_Human	Protein processing in endoplasmic reticulum	1/171	0.19271564324144907	0.2146151481552501	5.162091503267974	-2.8530763101358976	NFE2L2
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.2146151481552501	5.256819693945443	-2.919648521708157	NFE2L2
KEGG_2021_Human	Human cytomegalovirus infection	1/225	0.24621391857748554	0.26809960022881757	3.890873015873016	-1.9442968935376908	IL1B
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.28648958349558395	3.503584229390681	-1.6629804039719844	NFE2L2
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.38528619248417656	2.3584328129782675	-0.8341701676241932	CASP1
KEGG_2021_Human	Herpes simplex virus 1 infection	1/498	0.4709527127104428	0.48076422755857706	1.6926000447127207	-0.379898711570649	IL1B
KEGG_2021_Human	Pathways in cancer	1/531	0.4935522426966286	0.4935522426966286	1.580293501048218	-0.3089273055464	NFE2L2
